Organogenesis Holdings (ORGO) Cash from Operations Growth (5y) (2021 - 2026)
Organogenesis Holdings (ORGO) Cash from Operations Growth (5y) (2021 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 89.60 Bn | 87.73 Bn | - |
| 2 | Teva Pharmaceutical Industries | 35.90 Bn | 32.16 Bn | 1.97 Bn |
| 3 | Zoetis | 32.49 Bn | 30.55 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 27.56 Bn | 23.49 Bn | 4.39 Bn |
| 5 | United Therapeutics | 23.13 Bn | 20.97 Bn | 648.10 Mn |
| 6 | RedHill Biopharma | 21.80 Bn | 21.80 Bn | - |
| 7 | Viatris | 20.28 Bn | 18.48 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.75 Bn | 16.43 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.61 Bn | 12.18 Bn | 785.00 Mn |
| 10 | Organogenesis Holdings | 329.08 Mn | 236.98 Mn | 11.46 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 78.76% |
| Dec 31, 2025 | 11.17% |
| Sep 30, 2025 | -19.07% |
| Jun 30, 2025 | -28.63% |
| Mar 31, 2025 | -2.90% |
| Dec 31, 2024 | 29.97% |
| Sep 30, 2024 | 29.16% |
| Jun 30, 2024 | 19.05% |
| Mar 31, 2024 | -1.23% |
| Dec 31, 2023 | 21.15% |
| Sep 30, 2023 | 22.23% |
| Jun 30, 2023 | 20.57% |
| Mar 31, 2023 | -2.64% |
| Dec 31, 2022 | 35.70% |
| Sep 30, 2022 | 102.82% |
| Jun 30, 2022 | 121.27% |
| Mar 31, 2022 | 67.47% |
| Dec 31, 2021 | 41.65% |
| Mar 31, 2021 | -457.68% |